Latest Breaking News On - Ctla4 inhibition - Page 1 : comparemela.com

The expert panel discusses the 8-year follow-up data from CheckMate 214 looking at nivolumab plus ipilimumab in first-line advanced RCC and provide clinical insights on treatment decisions.

Advanced renal cell carcinomaTerm follow upRenal cell carcinomaAdvanced rccCheckmate 214Metastatic clear cell rccCtla4 inhibitionMetastatic clear cell renal carcinoma